Peri-implantitis Market (2026 - 2033)

Peri-implantitis Market Summary

The global peri-implantitis market size was valued at USD 2.1 billion in 2025 and is projected to grow from USD 2.3 billion in 2026 to USD 3.8 billion by 2033, at a CAGR of 7.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 38.4% in 2025. The aging population is increasingly driving the demand for dental implants, as older individuals are more likely to experience tooth loss due to conditions such as periodontal disease, trauma, or poor oral hygiene.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

As dental implants become a common solution for replacing lost teeth, peri-implantitis, an infection, and inflammation around implants also rise. These implants can be susceptible to bacterial infections and tissue inflammation, particularly if proper care is not maintained. Consequently, as the demand for dental implants grows, there is a corresponding need for effective treatments to manage and prevent peri-implantitis, ensuring the longevity and success of these implants.

To learn more about this report, Download Free Sample Report

Cosmetic dental procedures, such as dental implants, have gained significant popularity, particularly among middle-aged and elderly individuals seeking to improve their appearance and restore lost teeth. As more people prioritize aesthetic outcomes, the demand for dental implants has surged, increasing awareness of potential complications such as peri-implantitis. Effective management of peri-implant diseases becomes essential to ensure that implants maintain their aesthetic appeal. This has created a growing need for treatments that can prevent or address peri-implantitis, helping patients preserve their dental implants long-term success and visual quality.

Technological advancements in dental implant technology, such as creating more biocompatible and durable implants, have significantly reduced the risk of peri-implantitis by enhancing the integration between the implant and surrounding tissue. In addition, new treatments, including laser-assisted therapy, antimicrobial coatings, and advanced diagnostic tools, are improving the detection and management of peri-implant infections. Innovations in treatment methodologies, such as photodynamic therapy, regenerative approaches, and refined surgical techniques, offer more effective ways to prevent and manage peri-implantitis. These advancements improve patient outcomes and drive growth in the peri-implantitis industry by providing more efficient, minimally invasive solutions.

Market Dynamics

Peri-implantitis treatments are adopted due to the rising number of dental implant procedures worldwide and the growing prevalence of peri-implant diseases associated with long-term implant use. Increasing awareness among dental professionals regarding the importance of early diagnosis and timely intervention is supporting the adoption of both non-surgical and surgical treatment approaches. In addition, rising dental healthcare expenditure, improving access to specialized periodontal and implant care, and greater emphasis on preserving dental implants rather than replacing them are contributing to market growth. The growing demand for implant decontamination systems, regenerative biomaterials, antimicrobial therapies, laser-assisted treatments, and implant surface debridement technologies, along with continuous advancements in regenerative techniques and minimally invasive treatment approaches, is further strengthening the global peri-implantitis treatment market. Furthermore, the aging population, increasing prevalence of periodontal disease, higher incidence of diabetes and smoking-related complications, and the expanding installed base of dental implants are expected to support continued market expansion.

Analyst Perspective

The peri-implantitis treatment market is positioned for steady growth, driven by the expanding global installed base of dental implants and the increasing prevalence of peri-implant diseases. Market expansion is supported by growing awareness among clinicians regarding early diagnosis, rising adoption of implant maintenance protocols, and increasing demand for therapies that preserve implants rather than require replacement. Unlike conventional periodontal treatments, peri-implantitis management often requires specialized surgical and non-surgical interventions, regenerative biomaterials, implant surface decontamination technologies, and adjunctive antimicrobial therapies, resulting in higher treatment value per procedure. Manufacturers offering comprehensive treatment portfolios that integrate regenerative solutions, antimicrobial products, implant maintenance systems, and advanced decontamination technologies are expected to strengthen their competitive position. As clinical evidence supporting regenerative and minimally invasive treatment approaches continues to expand, market leadership will depend on product efficacy, long-term clinical outcomes, practitioner adoption, regulatory compliance, and the ability to provide integrated solutions that improve implant survival and patient outcomes.

Method Type Insights

Based on method type, the surgical segment led the market with the largest revenue share of 58.6% in 2025 and is also expected to grow at the fastest CAGR over the forecast period, driven by the effectiveness of surgical interventions in thoroughly addressing peri-implantitis, particularly through procedures such as open flap debridement and bone regeneration techniques. These surgical methods are recognized for achieving better clinical outcomes than non-surgical approaches, making them the preferred choice for many dental professionals. As awareness of surgical treatment benefits grows among practitioners and patients, there is an increasing inclination towards these options. In addition, advancements in surgical techniques and technologies are enhancing success rates, further solidifying the surgical segment position in the peri-implantitis industry.

The non-surgical segment is projected to grow significantly over the forecast period, which can be attributed to a rising preference for less invasive treatment options that minimize patient discomfort and recovery time. Non-surgical methods, including mechanical debridement and laser therapy, are gaining traction due to their effectiveness in managing the early stages of peri-implantitis. Furthermore, as patients become more informed about their treatment choices, there is a growing demand for preventive care approaches that non-surgical treatments can provide. The increasing focus on maintaining oral health and preventing complications also contributes to expanding non-surgical within the peri-implantitis industry.

Regional Insights

North America dominated the peri-implantitis market with the largest revenue share of 38.4% in 2025, attributed to the advanced healthcare infrastructure and high prevalence of dental implants. The region benefits from a well-established network of dental professionals increasingly adopting innovative treatment modalities for peri-implantitis. In addition, patients growing awareness about oral health issues related to dental implants is increasing, leading to higher demand for effective treatment options. Combining a robust healthcare system and a proactive approach to dental care has created an environment conducive to the growth of the peri-implantitis industry. As lifestyle-related oral health problems continue to rise, North America remains a key player in the peri-implantitis market.

To learn more about this report, Download Free Sample Report

U.S. Peri-implantitis Market Trends

The peri-implantitis market in the U.S. held the largest share in the North America region in 2025, driven by an increasing number of dental implant procedures being performed across the country. As awareness of peri-implant diseases grows among practitioners and patients, there is an escalating demand for effective treatment solutions. The high rate of dental placements, coupled with an aging population requiring comprehensive dental care, further drives this market expansion. Moreover, ongoing research and development efforts in dental technologies enhance treatment options for peri-implantitis management.

Europe Peri-implantitis Market Trends

Europe peri-implantitis market dominated the global market with a revenue share of 29.8% in 2024, fueled by advanced dental care practices and high rates of implant usage across the continent. The region benefits from healthcare regulations that promote regular dental check-ups and early intervention strategies for oral diseases. In addition, European countries have established strong educational programs for dental professionals, enhancing their skills in effectively diagnosing and treating peri-implant conditions. The emphasis on research and innovation in European dentistry significantly improves treatment outcomes. As patient awareness regarding oral health increases, so does the demand for effective peri-implantitis treatments throughout Europe.

Germany peri-implantitis market dominated Europe with a significant revenue share in 2024, driven by its robust healthcare system and strong emphasis on research and development in dental technologies. German dental practices are known for their high standards and adoption of innovative treatment methods, including non-surgical approaches such as mechanical debridement and antimicrobial therapies. The country commitment to continuous education for dental professionals ensures that they stay updated on the latest advancements in peri-implantitis management. As patient expectations rise regarding treatment efficacy and comfort, Germany proactive approach positions it as a key player in this peri-implantitis industry.

Asia Pacific Peri-implantitis Market Trends

The Asia Pacific peri-implantitis market is anticipated to grow at the highest CAGR over the forecast period, which can be attributed to the increasing urbanization and rising disposable incomes across various countries, which enhance access to dental care services. Moreover, as public awareness of oral health improves alongside advancements in dental technology, more patients seek treatments for conditions such as peri-implantitis. The expansion of private healthcare facilities and specialized dental clinics also plays a crucial role in meeting this rising demand. As lifestyle changes contribute to higher incidences of oral health issues, the Asia Pacific region presents significant opportunities for growth within the peri-implantitis market.

Key Peri-implantitis Company Insights

Some key companies operating in the market include Pfizer Inc., Cadila Pharmaceuticals, GaronitPharma, Basic Pharma Life Science Pvt Ltd., and Prachi Pharmaceuticals Private Limited. Companies are undertaking strategic initiatives such as mergers, acquisitions, and product launches, to expand their market presence and address the evolving healthcare demands through neuroendocrine tumor treatment market.

• Pfizer Inc. offers a variety of products and solutions related to the peri-implantitis market. Its key offerings include antibiotics such as azithromycin and doxycycline, essential for controlling bacterial infections around dental implants. In addition, the company provides antiseptics such as chlorhexidine, which are used to reduce the microbial load during treatment.

• Cadila Pharmaceuticals offers a range of products focusing on effective management of dental infections. Its portfolio includes antibiotics such as amoxicillin and clavulanic acid, crucial for combating bacterial infections associated with peri-implantitis. The company also provides antiseptic solutions such as chlorhexidine to reduce microbial load during treatment.

Key Peri-implantitis Companies:

The following key companies have been profiled for this study on the peri-implantitis market.

• Pfizer Inc.

• Cadila Pharmaceuticals

• GaronitPharma

• Basic Pharma Life Science Pvt Ltd.

• Prachi Pharmaceuticals Private Limited.

• Geistlich Pharma India Pvt. Ltd.

• Healthy Life Pharma Private Limited.

• Zimmer Biomet.

• Institut Straumann AG

• Dentsply Sirona

Recent Developments

• In May 2023, Institut Straumann AG announced the full acquisition of GalvoSurge, a Swiss medical device producer specializing in implant care and maintenance solutions. This strategic move aimed to enhance treatment options for peri-implantitis by integrating GalvoSurge's innovative technology into its portfolio. The acquired device, which had received CE marking and was released to the market in 2020, presented a novel approach to addressing the challenges associated with peri-implantitis treatment.

Global Peri-implantitis Market Report Segmentation

This report forecasts global, regional, and country revenue growth and analyzes the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global peri-implantitis market report based on method type, and region:

To learn more about this report, Download Free Sample Report

• Method Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Surgical

    • Bone Regeneration

    • Open Flap Debridement

    • Implantoplasty

  • Non-surgical

    • Mechanical Debridement

    • Laser Debridement

    • Antibiotics

    • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.    

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The peri-implantitis market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each peri-implantitis segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations